Marinomed Biotech AG | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 11/14/2024 at 14:39, 6 days 22 hours ago

Marinomed Biotech AG Secures Creditor Approval for Restructuring Plan

Insolvency Proceedings Marinomed Biotech AG Restructuring Plan Creditor Approval Carragelose Sale
PRESS RELEASE

published on 11/14/2024 at 14:34, 6 days 22 hours ago

EQS-Adhoc: Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors
Marinomed Biotech AG announces unanimous approval of restructuring plan by creditors at final court hearing, involving sale of Carragelose business unit

Creditors Marinomed Biotech AG Restructuring Plan Court Hearing Carragelose Business Unit
BRIEF

published on 11/12/2024 at 07:50, 9 days 5 hours ago

Marinomed Biotech AG Reveals Clinical Success of Carragelose Nasal Spray

Clinical Trials Marinomed Biotech Carragelose Nasal Spray Allergic Rhinitis Decongestant
PRESS RELEASE

published on 11/12/2024 at 07:45, 9 days 5 hours ago

Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine
Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine, showing significant improvement in breathing for allergic rhinitis patients

Clinical Data Marinomed Biotech AG Carragelose Nasal Spray Allergic Rhinitis
BRIEF

published on 10/11/2024 at 12:53, 1 month 10 days ago

Marinomed Biotech AG Enters Negotiations for Carragelose Portfolio Sale

Asset Deal Marinomed Biotech AG Restructuring Process Carragelose Portfolio Contract Negotiations
PRESS RELEASE

published on 10/11/2024 at 12:48, 1 month 10 days ago

EQS-Adhoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
Marinomed Biotech AG initiates contract negotiations for the sale of Carragelose portfolio, aiming for long-term strategy through strategic company decision

Strategic Decision Sale Marinomed Biotech AG Carragelose Portfolio Contract Negotiations
BRIEF

published on 10/08/2024 at 07:50, 1 month 13 days ago

Marinomed Biotech AG Reports Positive Trial Results for Tacrolimus Eye Drops

Clinical Trial Bioavailability Marinosolv Tacrosolv Allergic Conjunctivitis
PRESS RELEASE

published on 10/08/2024 at 07:45, 1 month 13 days ago

Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
Marinomed Biotech AG publishes study results on Tacrolimus eye drops, showing significant alleviation of allergic eye inflammation. Potential treatment for inflammatory eye diseases

Marinomed Biotech AG Study Results Ocular Surface Tacrolimus Eye Drops Allergic Eye Inflammation
BRIEF

published on 09/24/2024 at 07:50, 1 month 27 days ago

Marinomed Biotech AG Reports Positive Clinical Results for Unique Carragelose Eye Drops

Marinomed Biotech AG Carragelose Clinical Results Eye Drops Dry Eye Syndrome
PRESS RELEASE

published on 09/24/2024 at 07:45, 1 month 27 days ago

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
Marinomed Biotech AG reports positive clinical results for Carragelose eye drops, improving dry eye symptoms by 54%. The eye drops are well tolerated and hold valid Medical Device Directive certificate

Marinomed Biotech AG Carragelose Clinical Results Dry Eye Eye Drops

1 2 ... 6

Accesswire

Published on 11/21/2024 at 13:00, 32 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 32 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 32 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 32 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 32 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 17 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 57 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 17 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 26 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 32 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 34 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 12 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 47 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 47 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE